|The CD9 cd9 (Catalog #MBS532713) is an Antibody produced from Mouse and is intended for research purposes only. The product is available for immediate purchase. The CD9 antibody (FITC) reacts with Human and may cross-react with other species as described in the data sheet. MyBioSource\'s CD9 can be used in a range of immunoassay formats including, but not limited to, Flow Cytometry (FC/FACS), Immunohistochemistry (IHC). Researchers should empirically determine the suitability of the CD9 cd9 for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The CD9 cd9 product has the following accession number(s) (GI #4502693) (NCBI Accession #NP_001760.1) (Uniprot Accession #P21926). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Mouse monoclonal CD9 antibody (FITC).
Biological Significance: CD9 antigen is a protein that in humans is encoded by the CD9 gene. The protein encoded by this gene is a member of the transmembrane 4 superfamily, also known as the tetraspanin family. Most of these members are cell-surface proteins that are characterized by the presence of four hydrophobic domains. The proteins mediate signal transduction events that play a role in the regulation of cell development, activation, growth and motility. Biohazard Information: This product contains sodium azide as preservative. Although the amount of sodium azide is very small appropriate care must be taken when handling this product.
Immunogen: CD9 antibody (FITC) was raised in mouse using human CD9 as the immunogen. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing CD9 are readily searchable from our website. Different antibodies against the same target such as CD9 may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results. CD9 also interacts with the following gene(s): CD36, HBEGF, ICAM1, ITGA3, ITGA6, KIT, PTGFRN. Breast Neoplasms, Carcinoma, Cardiovascular Diseases, Inflammation, Leukemia, Myeloid, Acute, Lung Neoplasms, Necrosis, Neoplasm Metastasis, Neoplasms, Experimental, Neoplasms, Germ Cell and Embryonal are some of the diseases may be linked to CD9 antibody (FITC). Blood, Bone, Bone Marrow, Embryonic Tissue, Kidney, Liver, Lung, Lymph Node, Placenta, Vascular tissues are correlated with this protein.